BR100 Increased By (0.24%)
BR30 Increased By (0.06%)
KSE100 Increased By (0.2%)
KSE30 Increased By (0.24%)
AGHA 6.75 Increased By ▲ 0.07 (1.05%)
BECO 4.39 Increased By ▲ 0.02 (0.46%)
BML 57.01 Decreased By ▼ -0.31 (-0.54%)
BOP 30.46 Increased By ▲ 0.11 (0.36%)
CNERGY 13.15 Increased By ▲ 0.03 (0.23%)
CSIL 5.45 Increased By ▲ 0.04 (0.74%)
FCCL 52.90 Increased By ▲ 0.11 (0.21%)
FFL 14.77 Increased By ▲ 0.05 (0.34%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 6.10 Increased By ▲ 0.01 (0.16%)
KOSM 5.81 Increased By ▲ 0.08 (1.4%)
LOTCHEM 26.55 Increased By ▲ 0.09 (0.34%)
MLCF 93.70 Increased By ▲ 0.54 (0.58%)
NBP 164.83 Increased By ▲ 0.17 (0.1%)
NCPL 55.70 Increased By ▲ 0.04 (0.07%)
NPL 61.23 Increased By ▲ 0.07 (0.11%)
OGDC 315.90 Decreased By ▼ -0.83 (-0.26%)
PACE 9.90 Increased By ▲ 0.03 (0.3%)
PAEL 35.65 Increased By ▲ 0.02 (0.06%)
PIBTL 14.99 Increased By ▲ 0.31 (2.11%)
PPL 225.91 Decreased By ▼ -1.00 (-0.44%)
PRL 93.61 Increased By ▲ 0.59 (0.63%)
PTC 60.15 Decreased By ▼ -0.11 (-0.18%)
SSGC 23.75 Decreased By ▼ -0.06 (-0.25%)
TBL 8.70 Decreased By ▼ -0.05 (-0.57%)
TELE 7.87 Increased By ▲ 0.07 (0.9%)
TPL 22.60 Increased By ▲ 0.25 (1.12%)
TPLP 12.90 Decreased By ▼ -0.07 (-0.54%)
TREET 22.26 Increased By ▲ 0.10 (0.45%)
TRG 56.76 Increased By ▲ 0.20 (0.35%)

ISLAMABAD: Pakistan Muslim League-Nawaz (PML-N) Supremo and former Prime Minister Nawaz Sharif on Tuesday filed an acquittal application before the Accountability Court in Toshakhana case against him, President Asif Ali Zardari, Senate Chairman Syed Yousaf Raza Gilani, and others.

The Accountability Court judge, Nasir Javed Rana, issued notices to parties concerned on Sharif’s plea seeking acquittal in the Toshakhana case and sought arguments during the next hearing to be held on May 23.

Sharif filed the plea through his counsel and his pleader, Rana Muhammad Irfan appeared before the court. Among those accused in the case are President Zardari, who has presidential immunity now, and Senate Chairman Yousaf Raza Gilani.

Copyright Business Recorder, 2024

Comments

Comments are closed for this article.